Stocktwits on MSN

Mirum Stock Slips On $820M Bluejay Deal — But Wall Street Calls The Hepatitis Drug Seal A 'Steal'

Brelovitug is a late-stage experimental drug being studied for chronic hepatitis delta virus infection. ・The transaction with ...
PharmiWeb

Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics, Expanding Global Leadership in Rare Disease

Planned acquisition of brelovitug for chronic hepatitis delta virus (HDV) with Breakthrough Therapy and PRIME ...
The Roanoke Times

Q&A: Alpha, beta, gamma, delta — how variants of the COVID-19 virus continue to evolve

The delta variant of SARS-CoV-2, the virus that causes COVID-19, has been making headlines as it has quickly become the most prevalent strain in America. But other variants of the virus are still out ...